A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo

Stefan G. Vanderweil, Shinya Amano, Wei Che Ko, Jillian M. Richmond, Michelle Kelley, Maryanne Makredes Senna, Andrea Pearson, Sandhya Chowdary, Celia Hartigan, Bruce Barton, John E. Harris*

*Corresponding author for this work

Research output: Contribution to journalArticle

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)150-151.e3
JournalJournal of the American Academy of Dermatology
Volume76
Issue number1
DOIs
StatePublished - Jan 1 2017

ASJC Scopus subject areas

  • Dermatology

Cite this

Vanderweil, S. G., Amano, S., Ko, W. C., Richmond, J. M., Kelley, M., Senna, M. M., Pearson, A., Chowdary, S., Hartigan, C., Barton, B., & Harris, J. E. (2017). A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo. Journal of the American Academy of Dermatology, 76(1), 150-151.e3. https://doi.org/10.1016/j.jaad.2016.06.015